DarioHealth (DRIO) Appoints New CFO as Zvi Ben-David Retires

Author's Avatar
2 days ago

Key Highlights:

  • DarioHealth appoints a new CFO, with a planned transition period until June.
  • Wall Street analysts predict a potential 265% increase in DRIO's stock price from the current level.
  • GuruFocus estimates suggest a significant upside based on the GF Value metric.

DarioHealth's Leadership Transition

DarioHealth (DRIO, Financial) has officially announced the upcoming retirement of its Chief Financial Officer, Zvi Ben-David, set for May 15. Stepping into the roles of CFO, treasurer, and secretary will be Chen Franco-Yehuda, who brings a wealth of experience, having previously held similar positions at Pluri. Ben-David will continue to support the company during this transition period until the end of June, ensuring a seamless shift in leadership.

Wall Street Analysts' Forecast

1914363744557887488.png

According to price targets set by three analysts, DarioHealth Corp (DRIO, Financial) could see its stock price reach an average of $2.67 within a year. Projections vary significantly, with a high estimate of $5.00 and a low of $1.00. This average target suggests a remarkable upside of 265.00% from the current price of $0.73. Investors can explore more detailed estimates on the DarioHealth Corp (DRIO) Forecast page.

Consensus from three brokerage firms places DarioHealth Corp's (DRIO, Financial) average brokerage recommendation at 2.0, characterizing the stock as "Outperform." This rating is part of a scale from 1 to 5, where 1 represents a Strong Buy and 5 indicates a Sell. This suggests that analysts hold a positive outlook regarding the company's future performance.

Estimating DRIO's Value with GuruFocus Metrics

According to GuruFocus estimates, the GF Value for DarioHealth Corp (DRIO, Financial) is projected to be $2.68 in one year. This projection indicates a potential upside of 266.82% from the current price of $0.7306. The GF Value represents GuruFocus' calculated fair value of the stock, based on historical trading multiples, past business growth, and anticipated future performance. Investors seeking deeper insights can refer to the DarioHealth Corp (DRIO) Summary page.

  • CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
  • Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
  • Double Buys: Companies that both Gurus and Insiders are buying
  • Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.